Fletcher Biosciences is developing a new generation of precision biologics that selectively target disease-driving immune cells. By combining high-throughput protein engineering with deep immunology expertise, we create therapies with unmatched specificity and safety. Our approach moves beyond broad immune modulation to deliver best-in-class targeted interventions.
Headquartered in Cambridge, Massachusetts, Fletcher Biosciences was founded in 2023 and operates at the intersection of protein design, immunology, and translational medicine.
Company Details
- Employees
- 1
- Founded
- -
- Address
- 700 Main St, Cambridge,massachusetts 02139,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.fletcherbio.com/
- HQ
- Cambridge, Massachusetts
Fletcher Biosciences Questions
Fletcher Biosciences's website is https://www.fletcherbio.com/
Fletcher Biosciences's LinkedIn profile is https://www.linkedin.com/company/fletcher-biosciences
Fletcher Biosciences has
1 employees.
View email and phone details for 1
employees at Fletcher Biosciences.
Fletcher Biosciences's industry is
Biotechnology Research
Fletcher Biosciences's top competitors are
Matrisome Bio,
Dacapo Brainscience,
K2b Therapeutics,
Nine Diagnostics,
Inndura Therapeutics,
Lilium Therapeutics,
Kano Therapeutics,
Ilios Therapeutics,
Cerberus Therapeutics,
Gensaic.
Fletcher Biosciences's categories are Biotechnology Research
Fletcher Biosciences's founding year is 2023
